Literature DB >> 26295007

Vigabatrin Retinal Toxicity First Detected with Electroretinographic Changes: A Case Report.

Dianne Barrett1, Jin Yang2, Tharikarn Sujirakul2, Stephen H Tsang3.   

Abstract

Vigabatrin is an effective antiepileptic drug (AED) typically used in the treatment of refractory partial seizures and infantile spasms. Its use, however, is limited due to the concern of retinal toxicity and subsequent visual field defects. Herewith in we describe a case of vigabatrin toxicity that illustrates electroretinographic (ERG) changes occur before imaging and visual field deterioration. Decrease in maximal ERG b: a ratio was observed before thinning of the retinal nerve fiber layer (RNFL) on optical coherence tomography (OCT).

Entities:  

Keywords:  Retinal toxicity; Vigabatrin

Year:  2014        PMID: 26295007      PMCID: PMC4540358          DOI: 10.4172/2155-9570.1000363

Source DB:  PubMed          Journal:  J Clin Exp Ophthalmol


  12 in total

1.  The ocular side effects of vigabatrin (Sabril): information and guidance for screening.

Authors:  M J Hawker; N J Astbury
Journal:  Eye (Lond)       Date:  2008-05-23       Impact factor: 3.775

Review 2.  Molecular and cellular mechanisms of excitotoxic neuronal death.

Authors:  Yan Wang; Zheng-Hong Qin
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

3.  Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina.

Authors:  G J Sills; P N Patsalos; E Butler; G Forrest; N Ratnaraj; M J Brodie
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

Review 4.  Retinal and cochlear toxicity of drugs: new insights into mechanisms and detection.

Authors:  Isabelle Audo; Mark E Warchol
Journal:  Curr Opin Neurol       Date:  2012-02       Impact factor: 5.710

Review 5.  Vigabatrin-associated retinal damage: potential biochemical mechanisms.

Authors:  M K Heim; B E Gidal
Journal:  Acta Neurol Scand       Date:  2012-05-26       Impact factor: 3.209

6.  Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

Authors:  G L Krauss; M A Johnson; N R Miller
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

Review 7.  Vigabatrin: 2008 update.

Authors:  L James Willmore; Mark B Abelson; Elinor Ben-Menachem; John M Pellock; W Donald Shields
Journal:  Epilepsia       Date:  2009-02       Impact factor: 5.864

8.  Attenuation of the retinal nerve fibre layer and reduced retinal function assessed by optical coherence tomography and full-field electroretinography in patients exposed to vigabatrin medication.

Authors:  Ulrika Kjellström; Sten Andréasson; Vesna Ponjavic
Journal:  Acta Ophthalmol       Date:  2013-02-07       Impact factor: 3.761

9.  Unilateral electronegative ERG in a presumed central retinal artery occlusion.

Authors:  Luiz H Lima; Wener Cella; Claudia Brue; Stephen H Tsang
Journal:  Clin Ophthalmol       Date:  2010-11-17

10.  Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors.

Authors:  Jin Yang; Matthew C Naumann; Yi-Ting Tsai; Joaquin Tosi; Deniz Erol; Chyuan-Sheng Lin; Richard J Davis; Stephen H Tsang
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

View more
  2 in total

1.  Therapeutic effect of the mesenchymal stem cells on vigabatrin-induced retinopathy in adult male albino rat.

Authors:  Ayat Mahmoud Domouky; Walaa M Samy; Walaa A Rashad
Journal:  Anat Cell Biol       Date:  2022-06-30

2.  Electronegative electroretinogram in the modern multimodal imaging era.

Authors:  Dhimas H Sakti; Haipha Ali; Maria Korsakova; Nonna Saakova; Nina Mustafic; Clare L Fraser; Robyn V Jamieson; Elisa E Cornish; John R Grigg
Journal:  Clin Exp Ophthalmol       Date:  2022-03-08       Impact factor: 4.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.